Thierry Abribat
18Patents
10h-index
19Co-inventors
69Inventor score
Filing activity: Mar 20, 1996 → May 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5834418A | Process for the preparation of platelet growth factors extract | Human Necessities | 104 | Expired |
| US6024093A | Proprioceptive sole or pedal device containing crystals for treatment of statural disorders | Human Necessities | 97 | Expired |
| US11046946B2 | PEGylated L-asparaginase | Emerging Cross-Sectional Technologies | 35 | Active |
| US9920311B2 | PEGylated L-asparaginase | Emerging Cross-Sectional Technologies | 34 | Active |
| US5861379A | Chimeric fatty body-pro-GRF analogs with increased biological potency | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5939386A | Chimeric fatty body-pro-GRF (1-29) analogs with increased biological potency | Emerging Cross-Sectional Technologies | 20 | Expired |
| US7316997B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 15 | Expired |
| US8435945B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US7893025B2 | Use of growth hormone releasing factor analogs in treating patients suffering from wasting | Human Necessities | 12 | Active |
| US8314066B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US6148822A | Proprioceptive sole or pedal device containing crystals for treatment of statural disorders | Human Necessities | 9 | Expired |
| US7067488B2 | Modified GLP-1 peptides with increased biological potency | Human Necessities | 4 | Expired |
| US8481489B2 | GH secretagogues and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US5817627A | Long-acting galenical formulation for GRF peptides | Human Necessities | 1 | Expired |
| USRE49736E1 | Pegylated L-asparaginase | General | 0 | Active |
| US11192932B2 | Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders | Chemistry; Metallurgy | 0 | Active |
| US10947285B2 | Compounds, compositions and uses thereof for improvement of bone disorders | Human Necessities | 0 | Active |
| US9550821B2 | Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.